RxDoctor Payments Data

Steven Falowski, MD

Neurological Surgery · Fountain Hill, PANPI 1720272800

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (40.6%), consulting fees and royalties or licence payments — rather than concentrated in one kind of arrangement. 48 manufacturers reported payments, led by Abbott at 55.5% of the total. Reporting peaked in 2019 at $661,281 and has fallen 53.9% since, to $304,945 in 2025. Among neurological surgery clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,957,684in general payments, 2019–2025

Across 3,016 payments — averaging $980.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$1.6M
  • Aurora Spine, Inc.$623K
  • Vertiflex, Inc.$163K
  • Boston Scientific$123K
  • Saluda Medical Americas, Inc.$121K
  • Medtronic$91K
  • plus $195K from 42 others
$432,416in research payments, 2019–2025

Across 207 payments — averaging $2088.97 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Abbott$179K
  • Saluda Medical Americas, Inc.$161K
  • Medtronic$50K
  • Nevro Corp.$25K
  • Boston Scientific$7K
  • Biotronik Inc.$6K
  • plus $4K from 2 others
$17,133in ownership & investment interests, 2019–2025

Across 8 payments — averaging $2141.63 each. An ownership or investment interest held by the physician or an immediate family member.

  • SPR Therapeutics, Inc$17K
  • Foundation Fusion Solutions, LLC$0

What the payments were for

  • Royalty or licence$302,78910%
  • Consulting fees$1,168,94340%
  • Speaking & faculty fees$1,201,20641%
  • Travel & lodging$199,9717%
  • Food & beverage$84,6293%
  • Education$550%
  • Entertainment$910%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,957,684 in reported general payments places this provider in the 95th percentile of 390 neurological surgery providers in Pennsylvania.

See all neurological surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$185,887
Medicare patients
195
Services billed
1,218

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tizanidine Hcl14$125
Tramadol Hcl18$56

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Fountain Hill

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →